US government pledges $2B for new initiative on biomanufacturing
Over the past few days, the Biden administration has been focused on new science efforts, particularly around cancer, and growing biomanufacturing in the US.
On Wednesday, the White House held a summit on biotech and biomanufacturing, revealing what it will spend to boost these efforts.
Brian Deese, director of the National Economic Council, said that the administration has been focused on a modern industrial strategy by placing public funds in efforts that invest in infrastructure and secure supply chains. He also said that the focus of the initiative is to increase the domestic manufacturing of APIs to limit the dependence on foreign suppliers as well as increase the domestic manufacturing capacity in general and create jobs.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.